Fortrea Holdings Inc. (FTRE) stock
FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3056% above fair value
$19.59−0.20 (-1.01%)
Close on Nov 17, 2026Market cap $1.89BP/E –Yield –
Fortrea profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Fortrea's profit margin for the twelve months ending Sep 30, 2026 was -2.6%. For fiscal 2025 it was -36.2%, against -12.2% the year before. The highest annual figure on record is 6.6% in fiscal 2022.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -36.2% | −24.0 |
| FY2024 | Dec 31, 2024 | -12.2% | −11.3 |
| FY2023 | Dec 31, 2023 | -0.9% | −7.4 |
| FY2022 | Dec 31, 2022 | 6.6% | +3.4 |
| FY2021 | Dec 31, 2021 | 3.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 0.1% | +2.4 |
| Q2 FY2026 | Jun 30, 2026 | -1.9% | +50.8 |
| Q1 FY2026 | Mar 31, 2026 | -3.7% | +82.7 |
| Q4 FY2025 | Dec 31, 2025 | -4.9% | +3.9 |
| Q3 FY2025 | Sep 30, 2025 | -2.3% | +1.9 |
| Q2 FY2025 | Jun 30, 2025 | -52.8% | −31.9 |
| Q1 FY2025 | Mar 31, 2025 | -86.4% | −71.2 |
| Q4 FY2024 | Dec 31, 2024 | -8.8% | −1.1 |
| Q3 FY2024 | Sep 30, 2024 | -4.1% | −2.2 |
| Q2 FY2024 | Jun 30, 2024 | -20.9% | −25.1 |
| Q1 FY2024 | Mar 31, 2024 | -15.3% | −17.1 |
| Q4 FY2023 | Dec 31, 2023 | -7.7% | −13.0 |
| Q3 FY2023 | Sep 30, 2023 | -2.0% | −9.9 |
| Q2 FY2023 | Jun 30, 2023 | 4.2% | −4.1 |
| Q1 FY2023 | Mar 31, 2023 | 1.8% | – |
| Q4 FY2022 | Dec 31, 2022 | 5.3% | – |
| Q3 FY2022 | Sep 30, 2022 | 7.9% | – |
| Q2 FY2022 | Jun 30, 2022 | 8.4% | – |
See a number that looks wrong?